Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection
J Infect
.
2022 Aug;85(2):e37-e39.
doi: 10.1016/j.jinf.2022.05.035.
Epub 2022 Jun 1.
Authors
Yidun Zhang
1
,
Jiaming Li
2
,
Lina Jiang
1
,
Qi Chen
3
,
Yingying Fu
2
,
Yifei Jin
2
,
Zehui Chen
1
,
Fei Tang
1
,
Xiaohong Zeng
1
,
Huixin Wen
1
,
Bing Lu
2
,
Li Li
4
,
Jing Zheng
5
,
Zhongyi Wang
6
Affiliations
1
Xiamen Center for Disease Control and Prevention, 681 Shengguang Road, Xiamen 361021, China.
2
Beijing Institute of Biotechnology, 20 Dongdajie Road, Beijing 100071, China.
3
Beijing Institute of Microbiology and Epidemiology, 27 Taiping Road, Beijing, 100850, China.
4
Xiamen Center for Disease Control and Prevention, 681 Shengguang Road, Xiamen 361021, China. Electronic address: 33216670@qq.com.
5
Xiamen Center for Disease Control and Prevention, 681 Shengguang Road, Xiamen 361021, China. Electronic address: 727744201@qq.com.
6
Beijing Institute of Biotechnology, 20 Dongdajie Road, Beijing 100071, China. Electronic address: zhongyi_wang@foxmail.com.
PMID:
35659545
PMCID:
PMC9158243
DOI:
10.1016/j.jinf.2022.05.035
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Aerosols
COVID-19*
Cell Line
Humans
SARS-CoV-2*
Substances
Aerosols